This also suggested that compared to DCIS_neg that do not have the potential to acquire HER2 amplification in HER2-negative breast cancer, DCIS_noamp exhibit distinct genomic aberrations that may serve as a favorable structure for the later acquisition of HER2 amplification in HER2-positive breast cancer. The gene discussed is ERBB2; the disease is breast cancer.